|
HS Code |
255595 |
| Product Name | Adenosine-5'-Diphosphate Disodium Salt |
| Cas Number | 20398-34-9 |
| Molecular Formula | C10H13N5Na2O10P2 |
| Molecular Weight | 427.17 g/mol |
| Synonyms | ADP disodium salt, Adenosine diphosphate disodium salt |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Temperature | −20°C |
| Purity | Typically ≥95% |
| Chemical Structure | Purine nucleoside diphosphate with two sodium ions |
| Ec Number | 243-527-2 |
| Ph Solution | Approximately 7.0 (50 mg/mL, H2O, 25°C) |
As an accredited Adenosine-5'-Diphosphate Disodium Salt factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white, sealed, labeled 1-gram vial, marked “Adenosine-5'-Diphosphate Disodium Salt, ≥98%,” with hazard and storage instructions. |
| Shipping | Adenosine-5'-Diphosphate Disodium Salt is shipped in tightly sealed, properly labeled containers, protected from moisture and light. It is transported under ambient conditions unless otherwise specified, compliant with relevant chemical transport regulations. Ensure prompt receipt and handling upon delivery to maintain product stability and quality. Not classified as hazardous for shipping. |
| Storage | Adenosine-5'-Diphosphate Disodium Salt should be stored at -20°C, protected from light and moisture. Keep the container tightly sealed in a dry, well-ventilated area. Avoid repeated freeze-thaw cycles, and allow the compound to equilibrate to room temperature before opening to prevent condensation. Ensure proper labeling and follow local regulations for chemical storage. |
Applications of Adenosine-5'-Diphosphate Disodium Salt in Industrial ManufacturingAdenosine-5'-Diphosphate Disodium Salt supports specialized industrial processes across the pharmaceutical, biotechnology, diagnostics, and research sectors. As the manufacturer, we supply bulk volumes and custom grades for downstream formulation and process integration. 1. Nucleotide Supplementation for Cell Culture MediaMajor cell culture facilities use this nucleotide as a critical component in formulating high-performance growth media. It supports primary and continuous mammalian cell lines where energy metabolism requires accurate phosphate donors. Production batches must address rapid ATP regeneration for biomanufacturing monoclonal antibodies, vaccines, and recombinant proteins. Quality assurance teams monitor nucleotide purity and source according to facility validation protocols to ensure batch reproducibility and downstream protein yield. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Component in Enzymatic ATP-Regeneration SystemsDownstream enzymatic manufacturing plants use the compound as an intermediary substrate within in vitro ATP-regeneration cycles or phosphate group transfer systems. These processes include diagnostic enzyme kit production and synthesis of biosensors, where precise nucleotide cycling is critical for extended enzyme function. QC departments rely on traceable batch documentation and certified purity, especially for export to regulated medical supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Standard Material in Analytical Biochemistry and LC CalibrationCommercial clinical testing and reference laboratories apply this chemical as a calibration standard in high-performance liquid chromatography (HPLC) and enzymatic assays for purine nucleotide quantification. Accurate, certificate-backed lots are required for linearity testing, method development, and long-term QC validation. As manufacturers, we guarantee batch uniformity and traceability demanded by certified reference labs for ISO and CAP accreditation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Substrate for Enzyme-Based Drug Development ResearchPharmaceutical R&D divisions utilize this salt as a substrate in kinetic studies for kinase enzyme modulation, high-throughput screening (HTS), and structure-activity relationship (SAR) investigations. Automated screening platforms depend on validated charge states and solubility characteristics for reproducible signal detection. Our direct supply ensures tight lot release controls and batch consistency for CRO and internal drug pipeline labs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Biochemical Reagent in Molecular Biology and GenomicsProduction facilities for PCR additives, ligases, and nucleic acid modifying enzymes source this material for applications requiring specific phosphate donors in DNA/RNA ligation and labeling protocols. Manufacturing lines validate supply chain origin for consistency and regulatory documentation. Custom-packaged batches serve downstream genomic reagent producers and scientific kit exporters. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Adenosine-5'-Diphosphate Disodium Salt prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Long hours go into every batch of Adenosine-5'-Diphosphate Disodium Salt we put out. From raw nucleotide handling to final packaging, our familiarity with the subtleties of this product defines its real-world value. ADP supplies fill a pivotal role in countless labs and factories, yet differences in quality can affect everything downstream. We see it not as another chemical, but as a refined biochemical whose handling rewards careful attention.
Let’s clarify what Adenosine-5'-Diphosphate Disodium Salt really means in our daily operations. Our model (CAS No. 16178-48-6) appears as a white to off-white powder, with a knack for high solubility in water and consistent purity batch after batch. Real-world purity often exceeds 98%, with absence of pyrogenicity and tight control on heavy metal content (typically under 10 ppm, sometimes much lower for those with stricter requirements). Molecular details are not just numbers for us—each lot’s atomic ratio and hydration state (often trihydrate, though we process anhydrous variants for specialty orders) get confirmed before release, and a tied-in moisture content ensures the powder flows exactly as needed in automated dispensers and manual dosing routines alike.
Adenosine-5'-Diphosphate Disodium Salt often gets lumped in with basic buffering agents or the broader nucleotide family. This misses the mark. ATP and ADP may work side by side in nature, but their shelf stability and chemical reactivity in lab setups diverge. ATP quickly loses phosphate groups and requires stabilizers when dissolved, while ADP offers longer viability, becoming a favorite in assays favoring tighter control. Our version stands apart from commodity sources through thicker controls at the purification stage, pulling out NAD, trace phosphates, and chloride more stringently. After years handling both research-grade and more technical ADP forms, the message is clear: unresolved impurities can skew results in kinase activity screens and other enzyme-driven measurements where ADP forms the backbone of a reaction profile.
Some ADP on the market arrives from contract producers stitched together with patchwork protocols, cutting corners in fermentative or chemical synthesis and relying heavily on end-stage filtration to mask upstream variances. In our facilities, lot-to-lot consistency comes from process control—think chromatography targeting side-product exclusion, no recourse to broad-spectrum precipitation, and careful avoidance of ammonia or oxidants that could leave untraceable contaminant levels. Each production window brings minor shifts: temperature, pH, biologic source. Staff—most with ten or more years at the bench—notice subtle cues (smell of the raw extract, filter cake behavior, ease of re-dissolution). These signals feed back into tweaks before a batch completes, so the product reflects hands-on experience rather than wishful factory automation.
Researchers working in phosphorylation cascades or ADP/ATP ratio monitoring depend on confidence between tubes. Poorly filtered ADP can drag in ribonucleotide traces, tripping up luciferase assays. Medical device sites need ADP for platelet aggregation tests, where even minute contaminants prompt false positives or data weirdness. We’ve fielded more than a few requests from university investigators frustrated with flocculation during resuspension. These issues don’t show up on skimpy import spreadsheets—they surface on the pipette tip when timelines are tight.
Certain process-scale users (diagnostic reagent makers, blood compatibility testers) ask for bulk lots. These scenarios need not just value, but traceability. A soggy powder or odd “caking” near the jar rim tells our crew the drying step needs review; similarly, the “clumping” so common in large ADP drums signals a missing anti-static measure or an overlong hold before sealing. Rather than push everything through a one-size-fits-all spec, we respond with batch documentation and adjust handling protocols based on the final user—never assuming someone’s downstream routine matches another’s.
Clients often bring in reference samples from other manufacturers, looking for ways to cut costs. More often than not, the side-by-side tells the story: controls with our ADP keep background noise in cell metabolism measurements in check, while off-brand powders spark unexplained spikes. We've witnessed ADP from non-specialist sources bring with it residual acetic acid scents or a faint brown tinge. While stabilizers may mask batch idiosyncrasies, longevity always falters. Orders meant for clinical diagnostics pick up a subtle cost overhead—not because we inflate prices, but because robust nucleoside separation, controlled lyophilization, and validated packaging methods guarantee that a product opened months after purchase still behaves as expected, no re-titration needed. Corporations running hundreds of 96-well plates daily can’t afford surprises from batch splits or mixed provenance lots.
Teams new to nucleotide chemistry often ask why ADP costs break above simpler phosphate salts, or whether they really “need” the higher grade versions. We point to actual cost of downstream troubleshooting. A clinical lab burning through controls burns through time and patient trust with inconsistent reagents. Over the years, we’ve watched projects founder—whether through unexpectedly high baseline noise in luminescence readouts or slow dissolution of an overloaded phosphate-laden powder. Every complaint traced back to shortcuts in upstream testing. Architecting a process with cleaner, more defined ADP isn’t just about luxury; it turns out more efficient in the long run. And as scale increases, so does the value of a stable, predictable product lot by lot.
Choices start at raw nucleotide procurement. Long ago, we determined that enzyme-based synthesis with native bacterial strains yields cleaner chains than non-enzymatic processes. This decision traps fewer truncated nucleotides and rare crosslinked products common to rapid, chemically driven synthesis routes. The tradeoff? Higher spend and longer cycle times. But side-by-side, the improvement in UV spectra, lower ash content, and neutron activation tests give end users less batch-to-batch troubleshooting. For those in kinetic or time-resolved systems, this removes hours wasted adjusting buffers or calibrating to an ever-moving baseline—real labor and real budget saved.
Some suppliers promise multi-year shelf life at room temperature, but anyone working regularly with ADP knows that air and trace moisture sap potency long before the best-by date arrives. We instruct our own team and partners: store desiccated at 2–8°C, avoid repeated freeze-thaw cycles, seal tightly under inert gas after opening larger jugs. We’ve trialed a range of packaging, from glass ampoules to moisture-proof foils, settling on double-sealed HDPE bottles for mid-range users, and vacuum-sealed pouches for bulk buyers. Careful packing and timely logistics do more than extend a claim on a data sheet; they reduce waste and eliminate variance that could sabotage a major run. All these measures get costed in, but the total spend shrinks when the powder dissolves on cue, batch after batch.
Many distributors present a parade of bullet-pointed differentiators: color, pH, some ISO badge. From the manufacturing floor, the real question is how ADP behaves where it counts. We keep a feedback loop going with a number of partner labs—sending test samples, reevaluating results, tuning purification as technology advances. For example, once a team in proteomics screening flagged a slow loss of signal using our standard ADP, which prompted an audit of the feedstock, uncovering a marginally higher sodium content that crept up after a change in water pre-treatment. Lab dialogue steered us to revert a single point in the workflow, restoring both shelf life and customer satisfaction. This level of hands-on, repeated scrutiny outpaces any agent’s static “meets standard” claim.
End users in energy metabolism, kinase research, and enzyme diagnostics credit clean ADP for reduced variability, sharper endpoints, and more reliable repeat studies. University groups tracking phosphorylation cycles detect a change in reaction rates when lower-quality ADP enters the mix, especially in high-precision HPLC or LC-MS workflows. In blood compatibility labs, minute imbalances from sodium or chloride impurities push their controls out of range. Through fielding these findings for years, we keep an open channel—adapting product lines to suit next-gen research without losing the old values of direct dialogue and honesty about what works or fails in our product line.
Tighter regulation and a fresh push for biocompatibility steer some ADP users into requesting pharmaceutical-grade or animal-origin-free supply. Manufacturing in response outfits our teams with stricter cross-contamination controls, augments cleanroom time, and often drives up analytical review post-synthesis. For ADP intended for in vivo applications, our controls wring out both endotoxins and protein traces to levels below regulatory thresholds. Small changes in the washing sequence or packaging can spell the difference between passing and failing even the most rigorous safety assessments; these are learned through cycles of review, not just regulatory paperwork. The end result may bump up costs, but produces a confidence—shared by both seasoned chemists and new teams—that a given lot matches both health and lab-use criteria. A core principle here is focusing on “what gets used and why,” not just defaulting to an overbuilt spec sheet that leaves buyers guessing what really matters for their processes.
You’d be surprised how often delivery beats out purity as the real choke point. A late batch or shipment exposed to excess humidity can erase weeks of manufacturing care. We learned early on to buffer logistics with local warehousing for precision needs, and to track batch aging proactively. Double-lining shipments and scheduling for shortest transit have quietly saved more projects than any fancy analytical upgrade. Small shops may overlook this; for us, every shipping cost links back to an end user depending on a live reaction or a real patient test panel. Packaging that shields from incremental water ingress, and inserts anti-static media, avoids those shipment-day headaches. These steps look invisible to buyers, but the first weigh-in or resuspension tells the underlying story every time.
Clients sometimes trial ADP as a commodity, thinking of it like basic salt or buffer. After dozens of requests for troubleshooting, the real truth emerges: a trace impurity may not show up to the naked eye, but the signal-to-noise ratio in critical tests plunges. By anticipating what “normal” should look like for different application types—aqueous dissolution, non-interference in coupled enzyme tests, no background coloration—we keep the tweaks and repairs on our side of the production floor, not yours. This hands-on awareness, not just standardized output, lets new and established labs actually finish what’s on their plate, instead of getting tripped up by variable chemicals.
If the market shared one opinion, the cheapest ADP would win out. Real work reveals a more complicated world: the most-ordered product is the one that dissolves clean, triggers no false positives, and comes with a trail of history that researchers and production managers can trust year to year. By fixing eyes on the full cycle—from origin, to controlled synthesis, to hands-on shipping and honest field feedback—we strip the guesswork away. The differences aren't abstract; they're found in smoother protocol runs, less time spent chasing errors, and higher trust between supply and end use. The product's real value is built batch by batch, informed by every problem report, every field trial, and every conversation that’s left us a little wiser than the last.
Supplying ADP isn’t just pouring powder into a jar. Hidden in every batch are chances for moisture to sneak in, for residual acids to remain, or for fine crystals to clump before the first use. These are not abstract production risks; our line supervisors address them daily, with constant tweaks to drying kinetics, in-process analytics, and environmental monitoring in storage bays. Issues with peptide cross-contamination from previous equipment cycles led us to introduce line clearance steps unique to the ADP workflow, over and above what the official regs called for. Downstream users saw a sharp drop in sporadic reactivity, and overnight, the feedback loop fed into our training and inspection records. These kinds of solutions work best because the incentive runs straight back from end user complaints through to manufacturing retraining and batch sign-off.
Even a mature ADP product line benefits from constant re-examination. For example, shifting regulatory definitions around “pharmaceutical” or “food” grade nucleotide salts sent us down new analytic paths, updating existing protocols for trace organic acids and particulate matter. Scrutiny hasn’t stopped; every incoming request to test for microplastics, or rare-earth metal residues, drives incremental upgrades. On our side of the table, we recognize no process sits still. With every policy shift—whether prompted by new purity rules or green chemistry pushes—our goal is to outpace the minimum, so the next batch out the door solves problems beyond the minimum expectation.
Adenosine-5'-Diphosphate Disodium Salt, for us, represents more than a chemical standard or a spot on a sales table. The product holds together years of collective memory, user feedback, and hard-won manufacturing lessons. Consistent results, controlled impurity profiles, and predictable reactivity grew out of direct effort and partnership with users willing to share both headaches and triumphs. For every technical upgrade, the thumbs-up still comes from benches facing deadlines, not from glossy brochures. That connection—between manufacturer process and user reality—sets apart an upgraded product from a generic supply. All told, these are the lessons written between the lines, batch after batch, every time the white powder leaves our production line.